European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

The European Union has announced the launch of the Magnetic Diagnostic Assay for Neurodegenerative Diseases (MADIA) – a project with the ultimate goal of improving diagnosis for those living with Parkinson’s and Alzheimer’s.

The project, which is in partnership with a range of international universities and institutions, will focus on the development of a novel device that will help clinicians perform a simple click and analysis to diagnose both conditions.

Dr Francisco Campos, of the Clinical Neurosciences Research Laboratory, said: “An early diagnosis is crucial to maximise the effectiveness of the treatments in order to mitigate the devastating effects of these illnesses and slow disease progression.

“MADIA is funded by the European Union’s Horizon 2020 research and innovation programme, and consists of a multitasking team with more than 50 professionals in the fields of biology, physics and engineering.”

For comprehensive information about Parkinson’s diagnosis please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Women and Parkinson's

The women blazing the trail in Parkinson’s tech and innovation

Have you heard about these Parkinson’s technology inventions?

Advances

From small steps to big leaps – 200 years of Parkinson’s disease research and therapy advancements

Advice from experts working to enhance Parkinson’s therapy options

Dopamine agonists for Parkinson’s: a simple introduction

Find out more about the Parkinson’s medication

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Parkinson’s Life’s #WomenAndParkinsons campaign – a series highlighting the unique experiences of the estimated three million women worldwide who live with the condition – has been shortlisted in the UK Content Awards 2020 in the ‘Not-for-Profit / Charity Content Campaign of the Year’ category. Since its launch in 2019 the #WomenAndParkinsons campaign has covered topics including: the impact of menstruation on medication; the difficulties surrounding pregnancy, childbirth and breastfeeding with Parkinson’s; the interaction between menopause, sex and Parkinson’s; how coronavirus is impacting the lives of women with the condition; and what’s behind the lack of focus on gender. Parkinson’s Life editor Simge Eva Dogan, said: “Our campaign has centered on voices that were previously unheard and started much-needed discussions about the specific needs and experiences of women who are living with Parkinson’s. Being recognised by this award will help us to build on the success of the campaign so far and continue…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Women and Parkinson's

The women blazing the trail in Parkinson’s tech and innovation

sponsored article

Advances

From small steps to big leaps – 200 years of Parkinson’s disease research and therapy advancements

PD in Practice

Dopamine agonists for Parkinson’s: a simple introduction

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

{title}

Subscribe

European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Women and Parkinson's

The women blazing the trail in Parkinson’s tech and innovation

sponsored article

Advances

From small steps to big leaps – 200 years of Parkinson’s disease research and therapy advancements

PD in Practice

Dopamine agonists for Parkinson’s: a simple introduction

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

{title}

Subscribe

Sign in